CEFOTAXIME AND AMINOGLYCOSIDE TREATMENT OF MENINGITIS CAUSED BY GRAM-NEGATIVE ENTERIC ORGANISMS

被引:30
作者
KAPLAN, SL [1 ]
PATRICK, CC [1 ]
机构
[1] BAYLOR UNIV, DEPT PEDIAT, MYERS BLACK SECT PEDIAT INFECT DIS, HOUSTON, TX 77030 USA
关键词
Cefotaxime; Gram-negative entertics; Meningitis;
D O I
10.1097/00006454-199011000-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We reviewed cases of Gram-negative enteric bacillary meningitis in infants and children treated with cefotaxime at Texas Children’s Hospital from January, 1984, through June, 1989. Seventeen of 20 children had an underlying condition predisposing to the development of meningitis. The etiologic organisms in these 20 children (2 days to 12 years old; median, 12 days old) were Klebsiella sp, 9; Escherichia coli, 4; Enterobacter cloacae, 3; Citrobacter diversus, 2; other, 2. With the exception of one isolate of Acinetobacter, all isolates were susceptible to cefotaxime. In addition to cefotaxime 17 children received an aminoglycoside intravenously. Children with meningitis caused by Klebsiella sp. or non-Kliebsiella organisms received cefotaxime for 31 ± 14 and 37 ± 17 days, respectively. Aminoglycosides were administered for 16 ± 10 days in both groups. Five children in each group also received intraventricular doses (1 to 25) of an aminoglycoside (9) or colistimethate (1). The mean durations of positive lumbar, ventricular cerebrospinal fluid or brain abscess cultures were 5.8 ± 4.7 and 7.2 ± 5.0 days after start of therapy in the Klebsiella and non- Klebsiella meningitis patients, respectively. Only three children were normal at the time of discharge or follow-up. Gram-negative enteric meningitis remains difficult to treat despite the excellent in vitro activity of cefotaxime against Gram-negative enterics, in part as a result of the predisposing conditions resulting in the development of this infection. © 1990 by Williams and Wilkins.
引用
收藏
页码:810 / 814
页数:5
相关论文
共 26 条
[11]   A PROSPECTIVE RANDOMIZED COMPARISON OF CEFOTAXIME VS AMPICILLIN AND CHLORAMPHENICOL FOR BACTERIAL-MENINGITIS IN CHILDREN [J].
JACOBS, RF ;
WELLS, TG ;
STEELE, RW ;
YAMAUCHI, T .
JOURNAL OF PEDIATRICS, 1985, 107 (01) :129-133
[12]  
Jones R., 1985, MANUAL CLIN MICROBIO, P972
[13]   ANTI-MICROBIAL ACTIVITY OF AMIKACIN COMBINATIONS AGAINST ENTEROBACTERIACEAE MODERATELY SUSCEPTIBLE TO 3RD-GENERATION CEPHALOSPORINS [J].
JONES, RN ;
PACKER, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (06) :985-989
[14]  
KAFETZIS DA, 1982, J PEDIATR-US, V100, P483
[15]  
KLEIN JO, 1986, PEDIATRICS, V75, P959
[17]   A COMPARISON OF AMPICILLIN-CEFOTAXIME AND AMPICILLIN-CHLORAMPHENICOL IN CHILDHOOD BACTERIAL-MENINGITIS - AN EXPERIENCE IN 55 PATIENTS [J].
LAPOINTE, JR ;
BELIVEAU, C ;
CHICOINE, L ;
JONCAS, JH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 :167-180
[18]   TREATMENT OF 160 CASES OF ACUTE BACTERIAL-MENINGITIS WITH CEFOTAXIME [J].
LECOUR, H ;
SEARA, A ;
MIRANDA, AM ;
CORDEIRO, J ;
SARMENTO, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 :195-202
[19]  
MCCRACKEN GH, 1980, LANCET, V1, P787
[20]   MOXALACTAM THERAPY FOR NEONATAL MENINGITIS DUE TO GRAM-NEGATIVE ENTERIC BACILLI - A PROSPECTIVE CONTROLLED EVALUATION [J].
MCCRACKEN, GH ;
THRELKELD, N ;
MIZE, S ;
BAKER, CJ ;
KAPLAN, SL ;
FAINGEZICHT, I ;
FELDMAN, WE ;
SCHAAD, U .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (11) :1427-1432